$188 Million is the total value of Invus Financial Advisors, LLC's 9 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 12.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CPNG | Sell | Coupang Inccl a | $40,696,259 | -19.9% | 2,766,571 | -9.2% | 21.65% | -22.3% |
RCUS | Arcus Biosciences Inc | $33,337,752 | -20.9% | 1,612,077 | 0.0% | 17.74% | -23.4% | |
OYST | Oyster Point Pharma Inc | $30,925,106 | +98.8% | 2,768,586 | 0.0% | 16.46% | +92.7% | |
NVCR | Novocure Ltd | $25,737,341 | -3.5% | 350,884 | 0.0% | 13.70% | -6.4% | |
TBLA | Taboola.com Ltd | $24,084,645 | +70.2% | 7,819,690 | 0.0% | 12.82% | +65.0% | |
Nu Hldgs Ltd | $22,722,607 | -7.5% | 5,582,950 | 0.0% | 12.09% | -10.3% | ||
ORIC | Oric Pharmaceuticals Inc | $5,934,617 | +84.1% | 1,007,575 | 0.0% | 3.16% | +78.4% | |
IONQ Inc | $3,450,000 | -32.0% | 1,000,000 | 0.0% | 1.84% | -34.0% | ||
New | IHS Holding Limited | $1,048,932 | – | 170,558 | +100.0% | 0.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Arcus Biosciences Inc | 16 | Q3 2023 | 24.7% |
Novocure Ltd | 16 | Q3 2023 | 25.4% |
Oric Pharmaceuticals Inc | 14 | Q3 2023 | 14.3% |
Oyster Point Pharma Inc | 13 | Q4 2022 | 44.5% |
Coupang Inc | 11 | Q3 2023 | 51.6% |
Taboola.com Ltd | 10 | Q3 2023 | 23.7% |
Unity Biotechnology Inc | 9 | Q4 2021 | 8.0% |
Yext Inc | 8 | Q3 2021 | 30.3% |
IONQ Inc | 8 | Q3 2023 | 7.2% |
Nu Hldgs Ltd | 6 | Q3 2023 | 25.4% |
View Invus Financial Advisors, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Invus Financial Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.